Pneumology - Original Articles
Early Access
Diagnostic yield of endobronchial ultrasound-guided transbronchial needle aspiration for isolated mediastinal lymphadenopathy in a tuberculosis-endemic region: first study from Northeast India
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 23 March 2026
184
Views
61
Downloads
Authors
Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a minimally invasive technique for evaluating mediastinal lymphadenopathy, especially in tuberculosis-endemic regions where differentiating infectious, inflammatory, and malignant causes remains challenging. This retrospective study aimed to assess the diagnostic yield of EBUS-TBNA in patients from the northeastern states of India, a region with a high burden of tuberculosis and limited diagnostic resources. A total of 74 patients with isolated mediastinal lymphadenopathy (IML) who underwent EBUS-TBNA between 2021 and 2023 at a tertiary care hospital in Meghalaya were included. The final diagnosis was based on histology, cartridge-based nucleic acid amplification test (CBNAAT), culture, and clinical-radiological follow-up for up to 1 year in inconclusive cases. EBUS-TBNA achieved an overall diagnostic yield of 78.6%. The most common diagnosis was malignancy (36.5%), followed by tuberculosis (23%), reactive lymphadenitis (13.5%), and sarcoidosis (5.4%). CBNAAT was positive in 47.1% of tuberculosis cases, with multidrug resistance detected in 11.7%. The sensitivity, specificity, positive predictive value, and negative predictive value of EBUS-TBNA were 90.6%, 100%, 100%, and 62.5%, respectively. To conclude, EBUS-TBNA is a safe, highly sensitive, and cost-effective diagnostic modality for IML in tuberculosis-endemic regions. The addition of CBNAAT enhances diagnostic precision and enables early detection of drug resistance. The study also highlights an emerging trend of higher malignancy rates in the Northeastern Indian population, underscoring the need for comprehensive evaluation in all cases of IML.
Downloads
Download data is not yet available.
Citations
Navani N, Lawrence DR, Kolvekar S, et al. Endobronchial ultrasound-guided transbronchial needle aspiration prevents mediastinoscopies in the diagnosis of isolated mediastinal lymphadenopathy: a prospective trial. Am J Respir Crit Care Med 2012;186:255-60.
Evison M, Crosbie PA, Morris J, et al. A study of patients with isolated mediastinal and hilar lymphadenopathy undergoing EBUS-TBNA. BMJ Open Respir Res 2014;1:e000040.
Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003;123:137S-46S.
Fiterman N, Berkman N, Kuint R. Predictors of malignant lymph node involvement in patients with mediastinal lymphadenopathy and previous cancer: a cohort study. Thorac Cancer 2022;13:631-6.
Roberts PF, Follette DM, von Haag D, et al. Factors associated with false-positive staging of lung cancer by positron emission tomography. Ann Thorac Surg 2000;70:1154-9.
Lewis JW Jr, Pearlberg JL, Beute GH, et al. Can computed tomography of the chest stage lung cancer? Yes and no. Ann Thorac Surg 1990;49:591-5.
McNally PA, Sharma S, Arthur ME. Mediastinoscopy. Treasure Island, FL, USA: StatPearls Publishing; 2026.
Hammoud ZT, Anderson RC, Meyers BF, et al. The current role of mediastinoscopy in the evaluation of thoracic disease. J Thorac Cardiovasc Surg 1999;118:894-9.
Farrow PR, Jones DA, Stanley PJ, et al. Thoracic lymphadenopathy in Asians resident in the United Kingdom: role of mediastinoscopy in initial diagnosis. Thorax 1985;40:121-4.
Coughlin M, Deslauriers J, Beaulieu M, et al. Role of mediastinoscopy in pretreatment staging of patients with primary lung cancer. Ann Thorac Surg 1985;40:556-60.
Rusch VW, Asamura H, Watanabe H, et al. The IASLC lung cancer staging project: a proposal for a new international lymph node map. J Thorac Oncol 2009;4:568-77.
Herth FJ, Eberhardt R, Vilmann P, et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration for sampling mediastinal lymph nodes. Thorax 2006;61:795-8.
Yasufuku K, Chiyo M, Koh E, et al. Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer. Lung Cancer 2005;50:347-54.
Yasufuku K, Nakajima T, Motoori K, et al. Comparison of endobronchial ultrasound, PET, and CT for lymph node staging of lung cancer. Chest 2006;130:710-8.
Dhamija A, Basu A, Sharma V. Mediastinal adenopathy in India: through the eyes of endobronchial ultrasound. J Assoc Physicians India 2015;63:15-8.
Gupta D, Dadhwal DS, Agarwal R, et al. EBUS-TBNA vs conventional TBNA in the diagnosis of sarcoidosis. Chest 2014;146:547-56.
Srinivasan A, Agarwal R, Gupta N, et al. Initial experience with real-time EBUS-TBNA from a tertiary care hospital in North India. Indian J Med Res 2013;137:803-7.
Tian Q, Chen LA, Wang HS, et al. EBUS-TBNA of undiagnosed mediastinal lymphadenopathy. Chin Med J 2010;123:2211-4.
Jernlas B, Nyberger H, Ek L, et al. Diagnostic yield and efficacy of EBUS-TBNA in mediastinal lymphadenopathy. Clin Respir J 2012;6:88-95.
Aljohaney AA. Real time endobronchial ultrasound transbronchial needle aspiration for the diagnosis of tuberculous intrathoracic lymphadenopathy: Saudi Arabian western region experience. Saudi Med J 2023;44:178-86.
Sarı Akyüz M, Keskin O, Çavuşoğlu Yalçın N, Özkaya M. Diagnostic use of endobronchial ultrasound (EBUS) guided transbronchial needle aspiration (TBNA) in intrathoracic tuberculosis. Haydarpasa Numune Med J 2025;65:131-5.
Zhou L, Yong Y, Ran X, et al. Diagnostic value of the Xpert MTB/RIF assay combined with endobronchial ultrasonography with a guide sheath for peripheral nodular pulmonary tuberculosis. BMC Infect Dis 2024;24:1017.
Hillemann D, Rüsch-Gerdes S, Boehme C, Richter E. Rapid molecular detection of extrapulmonary tuberculosis by GeneXpert MTB/RIF. J Clin Microbiol 2011;49:1202-5.
Ligthelm LJ, Nicol MP, Hoek KG, et al. Xpert MTB/RIF for rapid diagnosis of tuberculous lymphadenitis. J Clin Microbiol 2011;49:3967-70.
Tortoli E, Russo C, Piersimoni C, et al. Clinical validation of Xpert MTB/RIF for diagnosis of extrapulmonary tuberculosis. Eur Respir J 2012;40:442-7.
Zeka AN, Tasbakan S, Cavusoglu C. Evaluation of GeneXpert MTB/RIF for rapid diagnosis and rifampin resistance. J Clin Microbiol 2011;49:4138-41.
Dhasmana DJ, Ross C, Bradley CJ, et al. Performance of Xpert MTB/RIF in diagnosis of tuberculous mediastinal lymphadenopathy by EBUS. Ann Am Thorac Soc 2014;11:392-6.
Navani N, Molyneaux PL, Breen RA, et al. Utility of EBUS-TBNA in tuberculous intrathoracic lymphadenopathy: a multicenter study. Thorax 2011;66:889-93.
Geake J, Hammerschlag G, Nguyen P, et al. Utility of EBUS-TBNA for diagnosis of mediastinal tuberculous lymphadenitis: an Australian multicenter experience. J Thorac Dis 2015;7:439-48.
Eom JS, Mok JH, Lee MK, et al. Efficacy of TB-PCR using EBUS-TBNA samples in intrathoracic granulomatous lymphadenopathy. BMC Pulm Med 2015;15:166.
Mehta AA, Perathur A, Paul T, et al. Clinical utility of EBUS-FNA as the first modality in undiagnosed mediastinal lymph node in a TB-endemic country. Lung India 2022;39:583-6.
Li W, Zhang T, Chen Y, et al. Diagnostic value of convex probe EBUS-TBNA in mediastinal tuberculous lymphadenitis: a systematic review and meta-analysis. Med Sci Monit 2015;21:2064-72.
Chhajed PN, Vaidya PJ, Mandovra NP, et al. EBUS-TBNA in rapid microbiological diagnosis of drug-resistant mediastinal tuberculous lymphadenopathy. ERJ Open Res 2019;5:00008-2019.
Lucey O, Potter J, Ricketts W, et al. Utility of EBUS-TBNA in diagnosing mediastinal tuberculous lymphadenitis in East London. J Infect 2022;84:17-23.
Helb D, Jones M, Story E, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand near-patient technology. J Clin Microbiol 2010;48:229-37.
Öztomurcuk D, Terzi Ö, Demirci C, Kılıçaslan Z. Investigation of granulomatous inflammations in terms of tuberculosis diagnosis: a 5-year multicenter laboratory study. Turk Thorac J 2022;23:11-6.
Litinsky I, Elkayam O, Flusser G, et al. Sarcoidosis: TB or not TB? Ann Rheum Dis 2002;61:385-6.
Kuo CH, Lin SM, Lee KY, et al. Algorithmic approach by EBUS-TBNA for isolated intrathoracic lymphadenopathy in a TB-endemic country. J Formos Med Assoc 2014;113:527-34.
Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160:736-55.
Trisolini R, Lazzari Agli L, Tinelli C, et al. EBUS-TBNA for diagnosis of sarcoidosis in unselected populations. Respirology 2015;20:226-34.
Navani N, Booth HL, Kocjan G, et al. Combination of EBUS-TBNA with standard bronchoscopic techniques for diagnosis of stage I–II pulmonary sarcoidosis. Respirology 2011;16:467-72.
Nakajima T, Yasufuku K, Kurosu K, et al. The role of EBUS-TBNA for diagnosis of sarcoidosis: comparison with other bronchoscopic modalities. Respir Med 2009;103:1796-800.
Von Bartheld MB, Dekkers OM, Szlubowski A, et al. Endosonography vs conventional bronchoscopy for the diagnosis of sarcoidosis: the GRANULOMA randomized trial. JAMA 2013;309:2457-64.
Rani M, Bonu S, Jha P, et al. Tobacco use in India: prevalence and predictors of smoking and chewing in a national survey. Tob Control 2003;12:e4.
Kumar A, Oswal K, Singh R, et al. Assessment of areca nut use and dependency among people in Guwahati, Assam: a cross-sectional study. Ecancermedicalscience 2021;15:1198.
Deb R, Kumari S, Mohan M, et al. Factors influencing tobacco consumption among Khasi indigenous people in Northeast India. Indian J Community Med 2024;49:380-5.
Shanker N, Mathur P, Das P, et al. Cancer scenario in North-East India and need for an appropriate research agenda. Indian J Med Res 2021;154:27-35.
Gupta B, Johnson NW. Association of smokeless tobacco and betel quid without tobacco with oral cancer incidence in South Asia and the Pacific: a systematic review and meta-analysis. PLoS One 2014;9:e113385.
Ethics Approval
The study protocol was reviewed and approved by the Institutional Ethics Committee of North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS), Shillong, Meghalaya, India (Protocol No. P210/2024/210, dated 19th February 2024). The committee assessed the project as ethically unobjectionable.How to Cite
“Diagnostic Yield of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Isolated Mediastinal Lymphadenopathy in a Tuberculosis-Endemic Region: First Study from Northeast India”. 2026. Monaldi Archives for Chest Disease, March. https://doi.org/10.4081/monaldi.2026.3811.
Copyright (c) 2026 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.